This work package will confirm the role of the potential identified targets from the findings of the WP 1-4. Using animal models this WP will on the one side confirm the role of possible effectors and elucidate further the mechanisms and test therapeutic approaches in these animal models to improve fibrosis and portal hypertension linked to bacterial translocation and gut-liver-axis.
Partner:
TransHep/Goethe University Frankfurt
